{
  "test_metadata": {
    "patient_id": "PAT-LAB-002",
    "patient_name": "Female^Genetic-Patient",
    "dob": "19760512",
    "age": "48Y",
    "test_date": "2024-03-15",
    "test_type": "Multi-Gene Cancer Predisposition Panel",
    "lab": "GeneDiagnostics Munich"
  },
  "gene_mutations": {
    "brca1": {
      "result": "Pathogenic Variant Detected",
      "mutation": "c.68_69delAG",
      "location": "Exon 2",
      "zygosity": "Heterozygous",
      "significance": "HIGH - Breast/Ovarian Cancer Risk"
    },
    "brca2": {
      "result": "No pathogenic variants detected",
      "status": "Wild-type"
    },
    "tp53": {
      "result": "Likely pathogenic variant",
      "mutation": "c.742C>T (p.Arg248Trp)",
      "significance": "HIGH - Li-Fraumeni Syndrome Risk"
    },
    "pten": {
      "result": "No variants detected",
      "status": "Wild-type"
    }
  },
  "risk_assessment": {
    "breast_cancer_lifetime_risk": "65-87% (vs general population 12%)",
    "ovarian_cancer_risk": "39-46% (vs general population 1.4%)",
    "pancreatic_cancer_risk": "1-2%",
    "recommendation": "Prophylactic bilateral mastectomy and oophorectomy should be considered"
  },
  "counseling_recommendation": "Genetic counseling strongly recommended. Family screening indicated.",
  "genetic_counselor": "Dr. Anna Weber"
}